Advertisement
Home »

IFN-γ secretion of PBMC from non-drug-allergic control persons: Considerations for the validity of a positive lymphocyte transformation test.

Jun 19, 2023

ABOUT THE EXPERTS

  • Andreas Glässner

    Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany. Electronic address: andreas.glaessner@bfarm.de.

    Gerda Wurpts

    Department of Dermatology and Allergy, University Hospital Aachen, Aachen, Germany.

    Stefanie Röseler

    Department of Dermatology and Allergy, University Hospital Aachen, Aachen, Germany.

    Amir S Yazdi

    Department of Dermatology and Allergy, University Hospital Aachen, Aachen, Germany.

    Christine Krämer

    Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.

    Amol Fatangare

    Leibniz-Institute for Analytical Sciences (ISAS) e.V., Bunsen-Kirchhoff-Straße 11, 44139 Dortmund, Germany.

    Albert Sickmann

    Leibniz-Institute for Analytical Sciences (ISAS) e.V., Bunsen-Kirchhoff-Straße 11, 44139 Dortmund, Germany.

    Per Hoffmann

    Institute of Human Genetics, University of Bonn, Bonn, Germany; Life&Brain Center, Department of Genomics, University of Bonn, Bonn, Germany.

    Markus Nöthen

    Institute of Human Genetics, University of Bonn, Bonn, Germany; Life&Brain Center, Department of Genomics, University of Bonn, Bonn, Germany.

    Bernhardt Sachs

    Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany; Department of Dermatology and Allergy, University Hospital Aachen, Aachen, Germany.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement